- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0213167

Sterin Labs Private Limited
About Sterin Labs Private Limited
Data last updated:
Sterin Labs Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2022PTC165800. Its GSTIN is 29ABJCS3383D1Z3 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Srinivas Reddy Kamireddy and Miriyala Sundari Bhuvana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 60 – D Bommasandra Industrial Area Anekal Tq, Bangalore, Karnataka, India – 560099.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.02 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.29 Cr (net margin 32.1%) and EBITDA of ₹1.75 Cr (EBITDA margin 43.6%).
The company has about 7 employees on its provident fund (EPFO) records.
Sterin Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0213167). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Sterin Labs
Contact details
Sterin Labs Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 60 – D Bommasandra Industrial Area Anekal Tq, Bangalore, Karnataka, India – 560099
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sterin Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sterin Labs is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Sterin Labs Private Limited, buy the company report.
Financials of Sterin Labs Private Limited
FY 2025 filings availableSterin Labs Private Limited reported revenue of ₹4.02 Cr (up 479% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 479% in the latest year. EBITDA rose 325% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.75 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.29 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 43.6% | ||
| Net Profit Margin | 32.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sterin Labs Private Limited, buy the company report.
Board of directors of Sterin Labs Private Limited
Sterin Labs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivas Reddy Kamireddy | Director | 07 Sep 2022 | 4 Years 1 Months | Current |
| Miriyala Sundari Bhuvana | Director | 07 Sep 2022 | 4 Years 1 Months | Current |
| Ravindhar Reddy | Director | 07 Sep 2022 | 4 Years 1 Months | Current |
| Srinivasan Kamalanathan | Director | 07 Sep 2022 | 4 Years 1 Months | Current |
Peer comparison
Sterin Labs Private Limited is compared with the 7 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ua Digital Futures Lab (OPC) Private Limited | ₹4.06 Cr (FY 2025) | 404.0% | Bardez, Goa, India | |||
| Ott Scientific India Private Limited | ₹4.05 Cr (FY 2025) | 102.0% | New Delhi, Delhi, India | |||
| Transcell Oncologics Private Limited | ₹4.04 Cr (FY 2023) | 3.0% | Hyderabad, Telangana, India | |||
| Sterin Labs Private Limitedthis company | ₹4.02 Cr (FY 2025) | ₹1.29 Cr | 32.1% | 479.0% | 7 | Bangalore, Karnataka, India |
| Skanda Lifesciences Private Limited | ₹4.02 Cr (FY 2025) | 16.0% | Bangalore, Karnataka, India | |||
| Sugen Life Sciences Private Limited | ₹4 Cr (FY 2025) | -11.0% | Tirupati, Andhra Pradesh, India | |||
| Bycus Therapeutics Private Limited | ₹3.98 Cr (FY 2025) | 66823.0% | Hyderabad, Telangana, India | |||
| Novo Informatics Private Limited | ₹3.96 Cr (FY 2022) | 71.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sterin Labs Private Limited, buy the company report.
Auditor
Sterin Labs Private Limited is audited by Anil Malpani & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anil Malpani & Associates | FY 2023 | 014923S |
Shareholding
The shareholding of Sterin Labs Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sterin Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sterin Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sterin Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sterin Labs Private Limited has a workforce of 7 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Sterin Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABJCS3383D1Z3 | Karnataka | Active | 07 Nov 2022 |
To see the full GST registrations and return filing status of Sterin Labs Private Limited, buy the company report.
Recent activity
Sterin Labs Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Miriyala Sundari Bhuvana was appointed as Director on 07 Sep 2022.
Frequently asked questions
Sterin Labs is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2022 (4+ years old) and is registered under CIN U73100KA2022PTC165800.
Sterin Labs has 4 current directors:
- Srinivas Reddy Kamireddy - Director
- Miriyala Sundari Bhuvana - Director
- Ravindhar Reddy - Director
- Srinivasan Kamalanathan - Director
The latest financial statements of Sterin Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Sterin Labs is 29ABJCS3383D1Z3, registered in Karnataka.
The CIN (Corporate Identification Number) of Sterin Labs is U73100KA2022PTC165800. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sterin Labs was incorporated on 07 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sterin Labs by revenue are Ua Digital Futures Lab (OPC) Private Limited, Ott Scientific India Private Limited, Transcell Oncologics Private Limited, Skanda Lifesciences Private Limited, Sugen Life Sciences Private Limited and 2 more, all in the same principal business activity (scientific research and development).
Miriyala Sundari Bhuvana was appointed as Director on 07 Sep 2022. Ravindhar Reddy was appointed as Director on 07 Sep 2022. Srinivas Reddy Kamireddy was appointed as Director on 07 Sep 2022. Sterin Labs has 4 board changes on record in total.
Yes, Sterin Labs is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0213167).
The registered office of Sterin Labs is at Plot No 60 – D Bommasandra Industrial Area Anekal Tq, Bangalore, Karnataka, India – 560099.
Sterin Labs operates in the pharma industry, in the drug formulation and development segment.